You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Novel Coronavirus

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)

Active, not recruiting
  • Novel Coronavirus-induced Lung Fibrosis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Sep 30, 2022

COVID-19 Trial in Poriyya (VOX)

Recruiting
  • COVID-19
  • VOX
  • Poriyya, Israel
    Poriya Medical Center
Aug 7, 2022

Covid-19 Infection in Patients With Underlying Diseases

Not yet recruiting
  • Chronic Liver Disease
  • +3 more
  • underling disease
  • (no location specified)
Aug 1, 2023

Covid19 Trial in Be'er Ya'aqov (Breath Biopsy Analysis)

Recruiting
  • Covid19
  • Breath Biopsy Analysis
  • Be'er Ya'aqov, Israel
    Shamir Medical Center
Aug 8, 2022

COVID-19 Trial (Manzi Guben granules)

Not yet recruiting
  • COVID-19
  • Manzi Guben granules
  • (no location specified)
Feb 8, 2023

COVID-19, Lung Injury, Acute, Kidney Injury Trial in Richmond (L-ascorbic acid, Placebo)

Completed
  • COVID-19
  • +2 more
  • L-ascorbic acid
  • Placebo
  • Richmond, Virginia
  • +1 more
Jun 30, 2022

COVID-19, Hypoxia Trial in Richmond (L-ascorbic acid)

Completed
Has Results
  • COVID-19
  • Hypoxia
  • L-ascorbic acid
  • Richmond, Virginia
    Hunter Holmes Mcguire Veteran Affairs Medical Center
Feb 23, 2022

Coronavirus Infection Trial in Moscow (Probiotics)

Completed
  • Coronavirus Infection
  • Probiotics
  • Moscow, Russian Federation
    I.M. Sechenov First Moscow State Medical University
Jan 13, 2022

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial (Famotidine, Celecoxib, Placebo)

Not yet recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • (no location specified)
Aug 15, 2022

Covid19, Novel Coronavirus Pneumonia, Acute Respiratory Distress Syndrome Trial in Panorama City (MSC-exosomes delivered

Not yet recruiting
  • Covid19
  • +2 more
  • MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)
  • +2 more
  • Panorama City, California
    Mission Community Hospital
Mar 10, 2022

Prevention of COVID-19 Trial in Changsha (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • Prevention of COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Feb 6, 2022

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,

Active, not recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Miami, Florida
    US02-04: Integrated Health Solutions
Aug 15, 2022

COVID-19 Trial in Hangzhou (Recombinant novel coronavirus vaccine (CHO cells))

Recruiting
  • COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jan 11, 2022

COVID-19 Trial in Hangzhou (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jan 11, 2022

Prevention of COVID-19 Trial in Changsha (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • Prevention of COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention Preve
Feb 6, 2022

Acute Respiratory Failure Trial in Perugia (lung ultrasound assessment)

Recruiting
  • Acute Respiratory Failure
  • lung ultrasound assessment
  • Perugia, Umbria, Italy, Italy
    Università degli Studi di Perugia
Jan 26, 2022

Coronavirus Disease 2019 Trial in Changsha (Tetravalent influenza virus lysis vaccine, Recombinant new coronavirus vaccine (CHO

Recruiting
  • Coronavirus Disease 2019
  • Tetravalent influenza virus lysis vaccine
  • Recombinant new coronavirus vaccine (CHO cell) group
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Nov 3, 2021

COVID-19, Child, Only Trial in Qingdao (Jinzhen oral liquid or Jinhuaqinggan granules)

Recruiting
  • COVID-19
  • Child, Only
  • Jinzhen oral liquid or Jinhuaqinggan granules
  • Qingdao, Shandong, China
    Phase I Clinical Research Center
Aug 17, 2022

Infection of Upper Respiratory Tract Caused by 2019-nCoV Trial in Shanghai (SA55 Injection)

Recruiting
  • Infection of Upper Respiratory Tract Caused by 2019-nCoV
  • SA55 Injection
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 12, 2023

Observational Cohort of COVID-19 Patients in Hubei Province

Completed
  • 2019 Novel Coronavirus Disease
  • No intervention
  • Wuhan, Hubei, China
    Tongji Hospital
Nov 10, 2022

AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in Diagnosis

Completed
  • 2019 Novel Coronavirus Disease
  • +8 more
  • Diagnostic Test: Diagnostic Software as Medical Device
  • Sunrise, Florida
    Sunrise Research Institute
Jul 19, 2022

Prognostic Value of PtcO2 in Patients With COVID-19

Recruiting
  • COVID-19 Acute Respiratory Distress Syndrome
  • outcome
  • Subtype of COVID-19
  • Nanjing, Jiangsu, China
    Zhongda hospital
Jan 10, 2023

2019 Novel Coronavirus Infection Trial in Shanghai (PVP-I Nasal Irrigation and gargling)

Recruiting
  • 2019 Novel Coronavirus Infection
  • PVP-I Nasal Irrigation and gargling
  • Shanghai, Shanghai, China
    Ruijin Hospital,Shanghai Jiaotong University school of medicine
May 17, 2022

SARS-CoV-2, Coronavirus, COVID-19 Trial in Pécs (Personalized health education, General health education)

Terminated
  • SARS-CoV-2
  • +4 more
  • Personalized health education
  • General health education
  • Pécs, Hungary
    Institute for Translational Medicine, University of Pécs
Jan 31, 2022

COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)

Recruiting
  • COVID-19
  • Umbilical cord mesenchymal stem cells implantation
  • Comparator
  • Shijiazhuang, Hebei, China
    The First Hospital of Hebei Medical University
Feb 22, 2023